News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

August 3, 2023

Dr. Barbara Burtness, Head and Neck Cancer Committee Chair, on a new way to classify HPV-associated head and neck cancers

August 3, 2023

AACR’s Clinical Cancer Research publishes a review article, “The New NCI Precision Medicine Trials”

August 3, 2023

Researchers identify two new subtypes of HPV-associated head and neck cancers

July 31, 2023

Proceedings of the National Academy of Sciences publishes the discovery of two new subtypes of HPV-associated head and neck cancers

July 26, 2023

Attention medical and research trainees: Applications are now being accepted for the Edith Peterson Mitchell, MD Health Equity Travel Scholarship to attend the Fall 2023 Group Meeting

July 20, 2023

Press Release: ECOG-ACRIN adds a new treatment trial to the ComboMATCH precision medicine initiative

July 20, 2023

Dr. Pamela Kunz on what’s next after the successful E2211 trial for patients with neuroendocrine tumors

July 19, 2023

The Summer 2023 advocacy blog, Considering Clinical Trials, is now available

June 30, 2023

The May/June 2023 News from ECOG-ACRIN blog is now available

June 22, 2023

The ECOG-ACRIN Clinical Research Associates (CRA) Core Committee is seeking candidates

June 16, 2023

Media Advisory: Nature Medicine publishes key lessons from NCI-MATCH to guide future precision medicine trials

June 1, 2023

Press Release: ComboMATCH investigators are translating robust pre-clinical evidence for new anti-cancer drug combinations into a series of early-phase clinical trials

May 31, 2023

NCI-MATCH named among five innovative oncology therapies changing the game

May 31, 2023

Your daily guide to ASCO 2023 research presentations by ECOG-ACRIN and PrECOG

May 30, 2023

Group leaders talk with The Cancer Letter about the cisplatin chemotherapy shortage (login required)

May 17, 2023

Press Release: ECOG-ACRIN announces the recipients of its 2023 scientific leadership and mentorship awards

May 11, 2023

Press Release: Historic achievement for the ongoing InPACT penile cancer trial—100 patients enrolled thus far, the most ever to a prospective study in this extremely rare disease

April 29, 2023

A TAILORx post hoc analysis is the first to show racial and ethnic differences in locoregional breast cancer recurrence

April 28, 2023

JAMA Surgery publishes TAILORx analysis showing that racial and ethnic differences in locoregional breast cancer recurrence patterns are prevalent even in a clinical trial population with similar access to care

April 26, 2023

Two new studies shed light on cancer detection in dense breasts as researchers emphasize the need for the TMIST trial

 
ECOG-ACRIN Cancer Research Group